mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.55 |
0.0005 |